Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer

Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer is organized by Society for Translational Oncology (STO).

Released: 11/4/2020
Expires: 11/4/2022

Learning Objectives:
• Summarize the role of FGF and FGFR in cancer, including resistance mechanisms.
• Discuss data from clinical trials or FGFR inhibitors across cancer types.

Additional details will be posted as soon as information is available.